FIELD: genetic engineering; biotechnology.
SUBSTANCE: invention relates to the production of ribonucleoprotein complexes of the CRISPR-Cas system, and can be used to detect human immunodeficiency virus (HIV-1) RNA.
EFFECT: invention provides detection of single copies of RNA of human immunodeficiency virus (HIV-1) genome.
6 cl, 8 dwg, 4 tbl, 5 ex
Authors
Dates
2023-09-01—Published
2022-12-28—Filed